Poor performance status and brain metastases treatment: who may benefit from the stereotactic radiotherapy? Holub K, Louvel G. J Neurooncol 2021 Feb 15. pii: 10.1007/s11060-021-03712.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Holub K, Louvel G. Poor performance status and brain metastases treatment: who may benefit from the stereotactic radiotherapy? J Neurooncol 2021 Feb 15. pii: 10.1007/s11060-021-03712.
PMID: 33590401